References
- Rosenberg T, Schwartz M. X-linked ocular albinism: prevalence and mutations – a national study. Eur J Hum Genet. 1998;6:570–77. doi:https://doi.org/10.1038/sj.ejhg.5200226.
- Tsang SH, Sharma T. X-linked ocular albinism. Adv Exp Med Biol. 2018;1085:49–52. doi:https://doi.org/10.1007/978-3-319-95046-4_11.
- Charles SJ, Green JS, Grant JW, Yates JR, Moore AT. Clinical features of affected males with X linked ocular albinism. Br J Ophthalmol. 1993;77:222–27. doi:https://doi.org/10.1136/bjo.77.4.222.
- Charles SJ, Moore AT, Grant JW, Yates JR. Genetic counselling in X-linked ocular albinism: clinical features of the carrier state. Eye (Lond). 1992;6:75–79. doi:https://doi.org/10.1038/eye.1992.15.
- Bassi MT, Schiaffino MV, Renieri A, De Nigris F, Galli L, Bruttini M, Gebbia M, Bergen AA, Lewis RA, Ballabio A. Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome. Nat Genet. 1995;10:13–19. doi:https://doi.org/10.1038/ng0595-13.
- Schiaffino MV, Bassi MT, Galli L, Renieri A, Bruttini M, De Nigris F, Bergen AA, Charles SJ, Yates JR, Meindl A, et al. Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism. Hum Mol Genet. 1995;4:2319–25.
- Schiaffino MV, Baschirotto C, Pellegrini G, Montalti S, Tacchetti C, De Luca M, Ballabio A. The ocular albinism type 1 gene product is a membrane glycoprotein localized to melanosomes. Proc Natl Acad Sci USA. 1996;93:9055–60. doi:https://doi.org/10.1073/pnas.93.17.9055.
- D’Addio M, Pizzigoni A, Bassi MT, Baschirotto C, Valetti C, Incerti B, Clementi M, De Luca M, Ballabio A, Schiaffino MV. Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. Hum Mol Genet. 2000;9:3011–18. doi:https://doi.org/10.1093/hmg/9.20.3011.
- Oetting WS. New insights into ocular albinism type 1 (OA1): mutations and polymorphisms of the OA1 gene. Hum Mutat. 2002;19:85–92. doi:https://doi.org/10.1002/humu.10034.
- Schnur RE, Gao M, Wick PA, Keller M, Benke PJ, Edwards MJ, Grix AW, Hockey A, Jung JH, Kidd KK, et al. OA1 mutations and deletions in X-linked ocular albinism. Am J Hum Genet. 1998;62:800–09.
- Shiono T, Tsunoda M, Chida Y, Nakazawa M, Tamai M. X linked ocular albinism in Japanese patients. Br J Ophthalmol. 1995;79:139–43. doi:https://doi.org/10.1136/bjo.79.2.139.
- Bassi MT, Bergen AA, Bitoun P, Charles SJ, Clementi M, Gosselin R, Hurst J, Lewis RA, Lorenz B, Meitinger T, et al. Diverse prevalence of large deletions within the OA1 gene in ocular albinism type 1 patients from Europe and North America. Hum Genet. 2001;108:51–54.
- Xiao X, Zhang Q. Iris hyperpigmentation in a Chinese family with ocular albinism and the GPR143 mutation. Am J Med Genet A. 2009;149A:1786–88. doi:https://doi.org/10.1002/ajmg.a.32818.
- Fang S, Guo X, Jia X, Xiao X, Li S, Novel ZQ. GPR143 mutations and clinical characteristics in six Chinese families with X-linked ocular albinism. Mol Vis. 2008;14:1974–82.
- Zou X, Li H, Yang L, Sun Z, Yuan Z, Li H, Sui R. Molecular genetic and clinical evaluation of three Chinese families with X-linked ocular albinism. Sci Rep. 2017;7:33713. doi:https://doi.org/10.1038/srep33713.
- Zhou P, Wang Z, Zhang J, Hu L, Kong X. Identification of a novel GPR143 deletion in a Chinese family with X-linked congenital nystagmus. Mol Vis. 2008;14:1015–19.
- Liu J, Jia Y, Wang L, Bu J. A previously unidentified deletion in G protein‑coupled receptor causing X‑linked congenital nystagmus in a Chinese family. Indian J Ophthalmol. 2016;64:813–17. doi:https://doi.org/10.4103/0301-4738.195593.
- Sun T, Xu K, Ren Y, Xie Y, Zhang X, Tian L, Li Y. Comprehensive molecular screening in Chinese usher syndrome patients. Invest Ophthalmol Vis Sci. 2018;59:1229–37. doi:https://doi.org/10.1167/iovs.17-23312.
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405–24.
- Krill AE, Lee GB. The electroretinogram in albinos and carriers of the ocular albino trait. Arch Ophthalmol. 1963;69:32–38. doi:https://doi.org/10.1001/archopht.1963.00960040038008.
- Wack MA, Peachey NS, Fishman GA. Electroretinographic findings in human oculocutaneous albinism. Ophthalmology. 1989;96:1778–85. doi:https://doi.org/10.1016/s0161-6420(89)32662-5.
- Tomei F, Wirth A. The electroretinogram of albinos. Vis Res. 1978;18:1465–66. doi:https://doi.org/10.1016/0042-6989(78)90246-8.
- Faugère V, Tuffery-Giraud S, Hamel C, Claustres M. Identification of three novel OA1 gene mutations identified in three families misdiagnosed with congenital nystagmus and carrier status determination by real-time quantitative PCR assay. BMC Genet. 2003;4:1. doi:https://doi.org/10.1186/1471-2156-4-1.
- Preising M, Op de Laak JP, Lorenz B. Deletion in the OA1 gene in a family with congenital X linked nystagmus. Br J Ophthalmol. 2001;85:1098–103. doi:https://doi.org/10.1136/bjo.85.9.1098.
- Thomas MG, Kumar A, Mohammad S, Proudlock FA, Engle EC, Andrews C, Chan WM, Thomas S, Gottlob I. Structural grading of foveal hypoplasia using spectral-domain optical coherence tomography a predictor of visual acuity? Ophthalmology. 2011;118:1653–60. doi:https://doi.org/10.1016/j.ophtha.2011.01.028.
- Khan KN, Lord EC, Arno G, Islam F, Carss KJ, Raymond F, Toomes C, Ali M, Inglehearn CF, Webster AR, et al. Detailed retinal imaging in carriers of ocular albinism. Retina. 2018;38:620–28.